Top news of the week: 30.12.2022.
White House Seeks Input on the National Biotechnology and Biomanufacturing Initiative
The White House Office of Science and Technology Policy (OSTP) has issued a Request for Information seeking public input on how advances in biotechnology and biomanufacturing can help the ...
Aptamer: the York biotech working on precision cancer treatments
UK firm links with up global drug firms to make synthetic antibodies capable of binding to targets such as tumour cells
How a scrappy African start-up could forever change the world of vaccines
Afrigen is the linchpin of global project to use mRNA technology to empower low-resource countries to make their own vaccines against killer diseases from TB to HIV. What will it take to ...
New Frontiers in Vaccinology
Check our collection of reports exploring the last innovation and business trends in the biotechnology industry.
Lithuania Focused on Building a World-Leading Life Science Sector
Lithuania’s life science sector is fastest growing in the European Union.
Pivotal Years: Abivax’s Obefazimod Faces Phase III Test
Abivax is ringing in 2023 with a Phase III program under way for its lead candidate obefazimod in moderate to severe ulcerative colitis (UC).
Three years on, the pandemic — and our response — have been jolting. Here’s what even the experts didn’t see coming
In the hope that lessons for the next pandemic can be found in the things we didn’t anticipate this time, STAT asked 23 experts what had surprised them the most.